Whitehawk Therapeutics (WHWK) Change in Acquisitions & Divestments (2022 - 2026)

Whitehawk Therapeutics (WHWK) has reported Change in Acquisitions & Divestments for 5 consecutive years, with $38.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 162.82% year-over-year to $38.6 million; the TTM figure through Mar 2026 stood at $83.8 million (up 41.76% YoY), while the FY2025 annual figure was $59.8 million, down 5.51% from the prior year.
• Change in Acquisitions & Divestments eased to $38.6 million in Q1 2026 per WHWK's latest filing, from $39.8 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $51.2 million in Q2 2023 and bottomed at $2.0 million in Q3 2025.
• Historically, Change in Acquisitions & Divestments has averaged $23.3 million across 5 years, with a median of $17.1 million in 2023.
• On a YoY basis, Change in Acquisitions & Divestments climbed as much as 198.57% in 2025 and fell as far as 86.86% in 2025.
• Whitehawk Therapeutics' Change in Acquisitions & Divestments stood at $12.8 million in 2022, then surged by 44.02% to $18.4 million in 2023, then decreased by 27.47% to $13.3 million in 2024, then soared by 198.57% to $39.8 million in 2025, then dropped by 2.89% to $38.6 million in 2026.
• Business Quant data shows WHWK's Change in Acquisitions & Divestments at $38.6 million in Q1 2026, $39.8 million in Q4 2025, and $2.0 million in Q3 2025.